ADMA BIOLOGICS, INC. Proceeds from Contributed Capital
ADMA BIOLOGICS, INC. (ADMA) reported Proceeds from Contributed Capital of $156.08 thousand for the 67-month period ending 2011-12-31, per its 10-Q filed 2012-02-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2012-02-01
- ADMA BIOLOGICS, INC. proceeds from contributed capital for the quarter ending 2011-12-31 was $15.00K.
- ADMA BIOLOGICS, INC. proceeds from contributed capital for the quarter ending 2011-09-30 was $2.58K.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 64 month | Proceeds from Contributed Capital 67 month |
|---|---|---|---|---|
| 2011-12-31 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | $17.58K 10-Q · filed 2012-02-01 | $156.08K 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $2.58K 10-Q · filed 2011-10-28 | $141.08K 10-Q · filed 2011-10-28 | ||
| 2010-12-31 | $8.50K 10-Q · filed 2012-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |